Prestige Consumer Healthcare (NYSE:PBH) Lifted to “Buy” at Jefferies Financial Group

Prestige Consumer Healthcare (NYSE:PBHGet Rating) was upgraded by equities research analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a research note issued on Tuesday, Briefing.com reports. The firm currently has a $70.00 target price on the stock, up from their prior target price of $65.00. Jefferies Financial Group’s price target points to a potential upside of 21.85% from the stock’s current price.

PBH has been the subject of several other research reports. StockNews.com started coverage on shares of Prestige Consumer Healthcare in a research report on Thursday, March 31st. They set a “buy” rating for the company. Oppenheimer upgraded shares of Prestige Consumer Healthcare from a “market perform” rating to an “outperform” rating and set a $63.00 price objective for the company in a report on Monday. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, Prestige Consumer Healthcare presently has an average rating of “Buy” and a consensus target price of $76.40.

NYSE:PBH opened at $57.45 on Tuesday. Prestige Consumer Healthcare has a one year low of $46.12 and a one year high of $63.83. The firm has a market capitalization of $2.88 billion, a P/E ratio of 14.22, a P/E/G ratio of 1.60 and a beta of 0.58. The company has a fifty day moving average of $54.75. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.25 and a current ratio of 2.04.

Prestige Consumer Healthcare (NYSE:PBHGet Rating) last released its quarterly earnings data on Thursday, May 5th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.89 by $0.02. Prestige Consumer Healthcare had a net margin of 18.90% and a return on equity of 14.08%. The firm had revenue of $266.94 million for the quarter, compared to the consensus estimate of $258.25 million. During the same period in the previous year, the company earned $0.79 earnings per share. The company’s quarterly revenue was up 12.3% on a year-over-year basis. On average, equities research analysts expect that Prestige Consumer Healthcare will post 4.27 earnings per share for the current year.

Hedge funds have recently bought and sold shares of the business. Campbell & CO Investment Adviser LLC bought a new stake in Prestige Consumer Healthcare in the 1st quarter worth approximately $209,000. Burney Co. increased its stake in shares of Prestige Consumer Healthcare by 1.9% during the first quarter. Burney Co. now owns 341,390 shares of the company’s stock valued at $18,073,000 after buying an additional 6,416 shares during the period. DCM Advisors LLC grew its stake in Prestige Consumer Healthcare by 22.2% in the first quarter. DCM Advisors LLC now owns 12,571 shares of the company’s stock worth $666,000 after purchasing an additional 2,281 shares during the period. Swiss National Bank grew its stake in Prestige Consumer Healthcare by 7.5% in the first quarter. Swiss National Bank now owns 118,400 shares of the company’s stock worth $6,268,000 after purchasing an additional 8,300 shares during the period. Finally, Teacher Retirement System of Texas grew its stake in Prestige Consumer Healthcare by 433.0% in the first quarter. Teacher Retirement System of Texas now owns 51,272 shares of the company’s stock worth $2,714,000 after purchasing an additional 41,653 shares during the period.

Prestige Consumer Healthcare Company Profile (Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Featured Articles

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.